Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.

[1]  S. Garland,et al.  High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. , 2006, The Journal of infectious diseases.

[2]  J. French,et al.  Readily treatable reproductive tract infections and preterm birth among black women. , 2006, American journal of obstetrics and gynecology.

[3]  R. Ness,et al.  Variability of Bacterial Vaginosis Over 6- to 12-Month Intervals , 2006, Sexually transmitted diseases.

[4]  P. Nyirjesy,et al.  Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. , 2006, American journal of obstetrics and gynecology.

[5]  G. Reid,et al.  Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. , 2006, Microbes and infection.

[6]  E. D. Hapsari,et al.  Clinical characteristics of vaginal discharge in bacterial vaginosis diagnosed by Nugent's criteria. , 2006, Clinical and experimental obstetrics & gynecology.

[7]  S. Hillier.  The complexity of microbial diversity in bacterial vaginosis. , 2005, The New England journal of medicine.

[8]  J. Marrazzo,et al.  Molecular identification of bacteria associated with bacterial vaginosis. , 2005, The New England journal of medicine.

[9]  Michelle de Souza,et al.  Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. , 2005, The Journal of infectious diseases.

[10]  L. Meyn,et al.  Microbiologic Response to Treatment of Bacterial Vaginosis with Topical Clindamycin or Metronidazole , 2005, Journal of Clinical Microbiology.

[11]  G. Reid,et al.  Complexity of vaginal microflora as analyzed by PCR denaturing gradient gel electrophoresis in a patient with recurrent bacterial vaginosis. , 2005, Infectious diseases in obstetrics and gynecology.

[12]  J. Marrazzo.  Evolving issues in understanding and treating bacterial vaginosis , 2004, Expert review of anti-infective therapy.

[13]  Jun Zhang,et al.  Vulvovaginal Symptoms in Women With Bacterial Vaginosis , 2004, Obstetrics and gynecology.

[14]  L. Morelli,et al.  Utilization of the Intestinal Tract as a Delivery System for Urogenital Probiotics , 2004, Journal of clinical gastroenterology.

[15]  G. Reid,et al.  Detection of Atopobium vaginae in Postmenopausal Women by Cultivation-Independent Methods Warrants Further Investigation , 2004, Journal of Clinical Microbiology.

[16]  J. Fortenberry,et al.  Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis , 2004, BMC infectious diseases.

[17]  L. Meyn,et al.  Risk Factors for Infection With Herpes Simplex Virus Type 2:: Role of Smoking, Douching, Uncircumcised Males, and Vaginal Flora , 2003, Sexually transmitted diseases.

[18]  G. Reid,et al.  Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. , 2003, FEMS immunology and medical microbiology.

[19]  M. Krohn,et al.  Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  G. Reid,et al.  Improved Understanding of the Bacterial Vaginal Microbiota of Women before and after Probiotic Instillation , 2003, Applied and Environmental Microbiology.

[21]  S. Cauci,et al.  Correlation of local interleukin-8 with immunoglobulin A against Gardnerella vaginalis hemolysin and with prolidase and sialidase levels in women with bacterial vaginosis. , 2002, The Journal of infectious diseases.

[22]  G. Reid,et al.  Lactobacillus strains and vaginal ecology. , 2002, JAMA.

[23]  E. Bosmans,et al.  Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis , 2002, BJOG : an international journal of obstetrics and gynaecology.

[24]  R. Kaul,et al.  New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. , 2001, Immunology letters.

[25]  A. Bruce,et al.  Oral probiotics can resolve urogenital infections. , 2001, FEMS immunology and medical microbiology.

[26]  G. Reid,et al.  Implantation of Lactobacillus casei var rhamnosus into vagina , 1994, The Lancet.

[27]  M A Krohn,et al.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation , 1991, Journal of clinical microbiology.